Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients, Pressure Control and Pupil Effects

Trial Profile

The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients, Pressure Control and Pupil Effects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Brimonidine (Primary) ; Phenylephrine; Tropicamide
  • Indications Dry age-related macular degeneration; Glaucoma; Ocular hypertension
  • Focus Therapeutic Use

Most Recent Events

  • 07 Nov 2017 Status changed from recruiting to completed.
  • 18 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Nov 2017.
  • 18 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Nov 2017.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top